Shire revenue decreased from $15.2 billion in 2017 to $43 million in 2018, a 99.7% decrease.

Annual Revenue (£)

Shire revenue was £42.95 m in FY, 2018

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018
Revenue£11.40 b$15.16 b£42.95 m
Q1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q2, 2017Q2, 2018Q3, 2018
Revenue$816.20 m$849.40 m$874.30 m$972.20 m$1.06 b$1.09 b$1.17 b$1.21 b$1.10 b$1.16 b$1.27 b$1.24 b$1.35 b$1.49 b$1.66 b$1.71 b$2.43 b$3.75 b$3.92 b$3.87 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Shire revenue breakdown by business segment: 20.6% from Hematology, 22.9% from Neuroscience, 16.1% from Internal Medicine, 12.7% from Genetic Diseases, 26.0% from Immunology and 1.7% from Other

FY, 2017FY, 2015FY, 2016
Hematology3.79 b2.24 b
Neuroscience2.66 b2.20 b2.49 b
Internal Medicine1.67 b1.50 b1.76 b
Oncology261.70 m130.50 m
Ophthalmology259.20 m54.40 m
Genetic Diseases1.44 b1.34 b1.39 b
Immunology4.37 b1.06 b2.83 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.